IDXX vs LNTH
Idexx Laboratories Inc. and Lantheus Holdings, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | IDXX | LNTH |
|---|---|---|
| Revenue | $4.3B | $1.5B |
| Net income | $1.1B | $233.6M |
| Gross margin | 61.8% | 61.1% |
| Net margin | 24.6% | 15.2% |
| Return on equity | 66.2% | 21.4% |
| Diluted EPS | $13.08 | $3.41 |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | $1.1B | · |
| Equity | $1.6B | $1.1B |
| Net debt / equity | 0.17× | 0.19× |
| Current ratio | 1.23× | 2.70× |
| Revenue CAGR 5y | 9.7% | 35.3% |
| Profit CAGR 5y | 12.7% | · |
IDXX bills 2.8× the revenue of LNTH, and keeps more of each dollar of revenue as profit (24.6% against 15.2%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | IDXX | LNTH |
|---|---|---|
| FY2025 | $4.3B | $1.5B |
| FY2024 | $3.9B | $1.5B |
| FY2023 | $3.7B | $1.3B |
| FY2022 | $3.4B | $935.1M |
| FY2021 | $3.2B | $425.2M |
| FY2020 | $2.7B | $339.4M |
| FY2019 | $2.4B | $347.3M |
| FY2018 | $2.2B | $343.4M |
| FY2017 | $2.0B | $331.4M |
| FY2016 | $1.8B | $301.9M |
Bottom line
| Fiscal year | IDXX | LNTH |
|---|---|---|
| FY2025 | $1.1B | $233.6M |
| FY2024 | $887.9M | $312.4M |
| FY2023 | $845.0M | $326.7M |
| FY2022 | $679.1M | $28.1M |
| FY2021 | $744.8M | $-71.3M |
| FY2020 | $581.8M | $-13.5M |
| FY2019 | $427.7M | $31.7M |
| FY2018 | $377.0M | $40.5M |
| FY2017 | $263.1M | $123.4M |
| FY2016 | $222.0M | $26.8M |
13 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$2,762,093,000 | IDXX |
| FY2024 | +$2,363,594,000 | IDXX |
| FY2023 | +$2,364,524,000 | IDXX |
| FY2022 | +$2,432,263,000 | IDXX |
| FY2021 | +$2,790,152,000 | IDXX |
| FY2020 | +$2,367,245,000 | IDXX |
| FY2019 | +$2,059,571,000 | IDXX |
| FY2018 | +$1,869,868,000 | IDXX |
| FY2017 | +$1,637,680,000 | IDXX |
| FY2016 | +$1,473,570,000 | IDXX |
| FY2015 | +$1,308,431,000 | IDXX |
| FY2014 | +$1,184,207,000 | IDXX |
| FY2013 | +$1,093,386,000 | IDXX |
IDXX has reported the higher revenue in every one of these 13 fiscal years. The gap has widened since the earliest year compared.
13 of 18 comparable fiscal years — a year missing data on either side is not counted.
9 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +9.5 pp | IDXX |
| FY2024 | +2.4 pp | IDXX |
| FY2023 | −2.1 pp | LNTH |
| FY2022 | +17.2 pp | IDXX |
| FY2021 | +39.9 pp | IDXX |
| FY2020 | +25.5 pp | IDXX |
| FY2019 | +8.7 pp | IDXX |
| FY2018 | +5.2 pp | IDXX |
| FY2017 | −23.9 pp | LNTH |
The higher net margin has changed hands between IDXX and LNTH over this period.
9 of 18 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
LNTH's net margin has been more volatile than IDXX's over the 9 comparable fiscal years — 15.1 percentage points of standard deviation against 3.5.
9 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between IDXX and LNTH over these 9 fiscal years — IDXX led in 7 and LNTH in 2.
9 of 18 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
IDXX's return on equity has been more volatile than LNTH's over the 6 comparable fiscal years — 29.4 percentage points of standard deviation against 22.5.
6 of 15 comparable fiscal years — a year missing data on either side is not counted.
Year by year
IDXX led in return on equity in every one of the 6 comparable fiscal years — a structural lead, not a recent swing.
6 of 15 comparable fiscal years — a year missing data on either side is not counted.